{"id":11546,"date":"2025-09-17T02:51:14","date_gmt":"2025-09-17T02:51:14","guid":{"rendered":"https:\/\/www.musclestationth.com\/?post_type=product&p=11546"},"modified":"2026-08-23T18:27:37","modified_gmt":"2026-08-23T18:27:37","slug":"mounjaro-kwikpen-2-5-mg-0-3ml-pre-filled-pen-1-piece-8-dose-%e0%b8%a1%e0%b8%b5%e0%b8%ad%e0%b8%a2","status":"publish","type":"product","link":"https:\/\/www.musclestationth.com\/en\/product\/mounjaro-kwikpen-2-5-mg-0-3ml-pre-filled-pen-1-piece-8-dose-%e0%b8%a1%e0%b8%b5%e0%b8%ad%e0%b8%a2\/","title":{"rendered":"Mounjaro KwikPen (Tirzepatide) \u2014 Lilly"},"content":{"rendered":"

Mounjaro KwikPen is a Lilly tirzepatide product name; the main image shows a KwikPen box.<\/p>

Label details recorded in the existing listing<\/h2>
Wording in the artwork<\/dt>
MOUNJARO KWIKPEN \u00b7 5 mg\/0.6 ml<\/dd>
Brand identified by the listing\/image<\/dt>
Lilly<\/dd>
Pictured format<\/dt>
Primary image shows a Mounjaro KwikPen carton<\/dd><\/dl>

These details are transcribed from existing artwork, not product testing. Confirm contents against the actual label and documentation for that presentation.<\/p>

What distinguishes this entry<\/h2>

The old name and package figures conflict with the primary image. A neutral name preserves the URL while the exact presentation awaits its actual label; the earlier approval wording is not registration evidence.<\/p>

About Tirzepatide<\/h2>

Tirzepatide acts at GIP and GLP-1 receptors. Medicine evidence applies to the studied product and indication, not automatically to another brand.<\/p>

Thai registration record for the related presentation<\/h2>

The Thai FDA record lists MOUNJARO 5 MG KWIKPEN, registration 1C 41\/67 (NC), with status \u201c\u0e04\u0e07\u0e2d\u0e22\u0e39\u0e48\u201d (active) and a special-control medicine classification. The record was updated on 16 June 2026.<\/p>

This identifies a registered presentation, not the physical pack in this listing. Its market version, label and supply documentation still need matching; the record does not verify stock or authenticity.<\/p>

Thai FDA \u2014 MOUNJARO 5 MG KWIKPEN registration record<\/a><\/p>

Frequently asked questions<\/h2>

Does the Thai registration record verify this listing\u2019s actual pack?<\/h3>

No. It confirms the named presentation\u2019s record, while the actual pack still needs matching label and supply documentation.<\/p>

What name and presentation does the existing listing identify?<\/h3>

MOUNJARO KWIKPEN \u00b7 5 mg\/0.6 ml \u2014 Primary image shows a Mounjaro KwikPen carton<\/p>

What should this entry be distinguished from?<\/h3>

The old name and package figures conflict with the primary image. A neutral name preserves the URL while the exact presentation awaits its actual label; the earlier approval wording is not registration evidence.<\/p>

What details help identify this listing in an enquiry?<\/h3>

Provide the name Mounjaro KwikPen (Tirzepatide) \u2014 Lilly, this page link and a readable label image to identify the presentation. General enquiries: LINE @musclestationth.<\/p>

Related information<\/h2>

Read about Tirzepatide<\/a> \u00b7 Browse Tirzepatide entries<\/a><\/p>

Sources<\/h2>